In recent times, a controversial study has stirred significant concerns regarding the safety and effectiveness of COVID-19 mRNA vaccines. This study, conducted by Correlation Research in the Public Interest, has analyzed data from 17 different countries to investigate the impact of these vaccines on all-cause mortality. The results, although striking, warrant careful scrutiny and understanding.
Analyzing the Vaccine-Dose Fatality Rate (vDFR)
The core focus of the study was to quantify the vaccine-dose fatality rate (vDFR) across all age groups. The vDFR is a metric that measures the ratio of vaccine-induced deaths to the total number of vaccines administered to the population. The researchers uncovered a vDFR of 1 death per 800 injections, spanning across all ages and countries.
To put this into perspective, this means that, of the 13.25 billion vaccine doses administered until September 2, 2023, 17 million individuals have succumbed to vaccine-related deaths. The implications of this are profound and necessitate further examination.
Understanding the Study Findings
The study’s findings can be summarized as follows:
- The Overall vDFR: The overall all-ages vDFR for the 17 countries involved in the study is approximately 0.126%. This percentage corresponds to an estimated 17.0 million COVID-19 vaccine-related deaths worldwide. This constitutes a significant global event, resulting in the loss of lives at an alarming rate.
- Lack of Preventative Effect: Perhaps most concerning is the revelation that this mass iatrogenic event did not measurably prevent any deaths. In essence, the vaccines did not fulfill their intended purpose of reducing mortality due to COVID-19.
The researchers delved into data from 17 countries in the equatorial and Southern Hemisphere regions. These countries included Argentina, Australia, Bolivia, Brazil, Chile, Colombia, Ecuador, Malaysia, New Zealand, Paraguay, Peru, Philippines, Singapore, South Africa, Suriname, Thailand, and Uruguay. Their analysis encompassed 9.1% of the global population and 10.3% of worldwide COVID-19 vaccine injections.
- Increased All-Cause Mortality: In all countries under scrutiny, all-cause mortality increased following the deployment of COVID-19 vaccines. This finding challenges the notion that these vaccines were universally effective in preventing deaths.
- Pre-Vaccination Excess Deaths: Surprisingly, nine of the 17 countries showed no detectable excess deaths before the commencement of the COVID-19 vaccination campaign, as per the World Health Organization’s declaration in March 2020.
- Seasonal Peaks: Notably, unprecedented peaks in all-cause mortality occurred in January and February 2022, coinciding with or following the rollout of vaccine boosters in 15 of the 17 countries examined.
- Excess Mortality During Vaccination Period: During the vaccination period beginning in January 2021, there were 1.74 million excess all-cause deaths, equating to one death per 800 vaccine injections across 17 countries.
- Age-Related vDFR: The vDFR showed an alarming exponential increase with age, reaching nearly 5% for individuals aged 90 and above who received a fourth vaccine dose.
The Expectation vs. Reality
One of the most critical observations made by the researchers is that if the vaccines were effective in preventing transmission, infection, or serious illness, there should have been a decrease in mortality rates following vaccine rollouts. However, the data paints a different picture. In many cases, mortality rates increased when vaccines were introduced.
No Evidence of Life-Saving Efficacy
Denis Rancourt, co-director of the Correlation Research in the Public Interest, concluded that the study found no evidence to suggest that the vaccines saved lives. Instead, the risk of death per injection was shown to increase exponentially with age, prompting a reconsideration of the prioritization of the elderly for vaccination.
This study raises significant concerns and necessitates further investigation into the safety and effectiveness of COVID-19 mRNA vaccines. It challenges the assumptions made by pharmaceutical companies and governments regarding the benefits of vaccination, and its findings cannot be ignored. Data from other countries also supports the observed increase in all-cause mortality when booster shots were introduced.
In conclusion, the study’s results call for an urgent reevaluation of vaccination strategies and a rigorous reexamination of vaccine safety. The welfare of individuals and the global population should remain at the forefront of this ongoing discussion.